← Back to catalogue
Europa Ultra CTO - Chronic Total Occlusion Coronary Balloon Catheter OTW 1.5mmx…
EUDAMEDClass III (EU MDR)
Ref EO15/15Model Europa Ultra™ Family
Identity
- Trade Name
- Europa Ultra™ EUDAMED
- Device Name
- Europa Ultra CTO - Chronic Total Occlusion Coronary Balloon Catheter OTW 1.5mmx15mm EUDAMEDEuropa Ultra Coronary Balloon Catheter EUDAMED
- Model / Reference
- EO15/15 EUDAMEDEuropa Ultra™ Family EUDAMED
Identifiers
- Primary DI / UDI-DI
- 07630033300643 EUDAMED
- Basic UDI-DI
- B-07630033300643 EUDAMED076300333EF_CBLCATHGG EUDAMED
- EMDN Code
- C010401020101 PTCA BALLOON DILATION CATHETERS EUDAMED
Classification
- Device Class
- Class III EUDAMED
- Market of Registration
- Romania EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Europa Ultra CTO - Chronic Total Occlusion Coronary Balloon Catheter OTW 1.5mmx… by Rontis Corporation SA — Class III — MDR, MDD — listed in EUDAMED
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
European Union Active
CE/MDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | B-07630033300643 | Class III | Active |
| EUDAMED | European Union | CE/MDD | B-07630033300643 | Class III | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Rontis Corporation SA
- EUDAMED SRN
- CH-MF-000031411
- Authorised Representative
- RONTIS HELLAS MEDICAL AND PHARMACEUTICAL PRODUCTS S.A. GR-AR-000023077
Sources (2)
- EUDAMED b995f1f2-cf2e-4b27-ac78-45be6ff12fc2 61 fields · synced Jul 18, 2026
- EUDAMED 98a01d8c-2dfc-496b-9e52-2614cbfd6459 61 fields · synced May 18, 2026